ARTICLE | Distillery Therapeutics
Therapeutics: δ-4-desaturase sphingolipid 1 (DEGS1)
February 4, 2016 8:00 AM UTC
Cell culture studies identified a DEGS1 inhibitor that could help treat prostate cancer. Chemical synthesis and in vitro testing of oxadiazole analogs identified a compound that decreased conversion o...